Showing results (1-10 of 48) with videos related to
Sort By:
Pageof 5
Internal Medicine Journal|September 27, 2007
Hepatitis B virus reactivation following immunosuppressive therapy: guidelines for prevention and managementJ S Lubel, A G Testro, P W AngusInternal Medicine Journal|June 6, 2013
Minimising time to treatment: targeted strategies to minimise time to thrombolysis for acute ischaemic strokeY J Tai, B YanJournal of Virology|January 1, 1985
Host genetic determinants of neurological disease induced by Cas-Br-M murine leukemia virusP M Hoffman, H C MorseJournal of Neuroimmunology|January 1, 1991
Virus-specific cytotoxic lymphocyte response in a neurotropic murine leukemia virus infectionD S Robbins, P M HoffmanJournal of Virology|August 1, 1993
Viral determinants that control the neuropathogenicity of PVC-211 murine leukemia virus in vivo determine brain capillary endothelial cell tropism of the virus in vitroM Masuda, P M Hoffman, S K RuscettiScience (New York, N.Y.)|March 22, 1996
Induction of protective CTL responses in newborn mice by a murine retrovirusM Sarzotti, D S Robbins, P M HoffmanInternal Medicine Journal|January 4, 2012
Does a 'code stroke' rapid access protocol decrease door-to-needle time for thrombolysis?Y J Tai, L Weir, P Hand, et al.Biochemical and Biophysical Research Communications|October 30, 1986
Altered cellular functions in a PC-12 cell clone chronically infected with retrovirusJ A Bilello, P M Hoffman, S R MaxJournal of Virology|August 1, 1986
Characterization of a progressive neurodegenerative disease induced by a temperature-sensitive Moloney murine leukemia virus infectionJ A Bilello, O M Pitts, P M HoffmanJournal of Neuroimmunology|August 1, 1991
Effects of viral specific cytotoxic lymphocytes on the expression of murine leukemia virus induced neurologic diseaseP M Hoffman, E F Cimino, D S RobbinsPageof 5